Wedbush Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Wedbush
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Wedbush. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Wedbush.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
TYRA Tyra Biosciences	$13.85 -0.4%	12/29/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$27.00	Low	View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 12/29/2023
MSFT Microsoft	$376.04 +0.2%	12/28/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$425.00 -> $450.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 12/28/2023
ALIT Alight	$8.53 -0.6%	12/28/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$11.00 -> $13.00	Low	View details for Wedbush rating of Alight (NYSE:ALIT) on 12/28/2023
EXPE Expedia Group	$151.79 -1.0%	12/27/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$115.00 -> $130.00	Low	View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023
CART Maplebear	$23.47 -1.6%	12/27/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$30.00 -> $26.00	Low	View details for Wedbush rating of Maplebear (NASDAQ:CART) on 12/27/2023
LYFT Lyft	$14.99 -3.5%	12/27/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$12.00 -> $14.00	Low	View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 12/27/2023
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
MELI MercadoLibre	$1,571.54 -0.6%	12/27/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$1,700.00 -> $1,800.00	Low	View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 12/27/2023
META Meta Platforms	$353.96 -1.2%	12/27/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$350.00 -> $420.00	Low	View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 12/27/2023
PINS Pinterest	$37.04 -0.6%	12/27/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$32.00 -> $35.00	Low	View details for Wedbush rating of Pinterest (NYSE:PINS) on 12/27/2023
BKNG Booking	$3,547.22 -0.1%	12/27/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$3,300.00 -> $3,850.00	Low	View details for Wedbush rating of Booking (NASDAQ:BKNG) on 12/27/2023
CTSH Cognizant Technology Solutions	$75.53 -0.4%	12/26/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$75.00 -> $85.00	Low	View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 12/26/2023
KRTX Karuna Therapeutics	$316.51 +0.1%	12/22/2023	Downgraded by	Wedbush	Analyst L. Chico	Outperform -> Neutral	$330.00	Low	View details for Wedbush rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/22/2023
TSLA Tesla	$248.48 -1.9%	12/22/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$310.00 -> $350.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 12/22/2023
BROS Dutch Bros	$31.67 -0.7%	12/21/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$35.00 -> $37.00	Low	View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 12/21/2023
LQDA Liquidia	$12.03 -0.3%	12/21/2023	Reiterated by	Wedbush	-	Underperform -> Underperform	$3.00	Low	View details for Wedbush rating of Liquidia (NASDAQ:LQDA) on 12/21/2023
MU Micron Technology	$85.34 -0.6%	12/21/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$95.00	Low	View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/21/2023
NFLX Netflix	$486.88 -0.7%	12/21/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$525.00	Low	View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 12/21/2023
AMZN Amazon.com	$151.94 -0.9%	12/21/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$180.00 -> $210.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 12/21/2023
WEN Wendy's	$19.48 -0.3%	12/21/2023	Downgraded by	Wedbush	Analyst N. Setyan	Outperform -> Neutral	$21.00	Low	View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 12/21/2023
CMG Chipotle Mexican Grill	$2,286.96 +0.4%	12/21/2023	Downgraded by	Wedbush	Analyst N. Setyan	Outperform -> Neutral	$2,400.00	Low	View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 12/21/2023
CAKE Cheesecake Factory	$35.01 -0.9%	12/21/2023	Upgraded by	Wedbush	Analyst N. Setyan	Neutral -> Outperform	$34.00 -> $40.00	Low	View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 12/21/2023
CAVA CAVA Group	$42.98 -3.7%	12/21/2023	Upgraded by	Wedbush	Analyst N. Setyan	Neutral -> Outperform	$35.00 -> $48.00	Low	View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 12/21/2023
KMX CarMax	$76.74 -1.4%	12/20/2023	Target Raised by	Wedbush	Analyst S. Basham	Overweight -> Overweight	$80.00 -> $90.00	Low	View details for Wedbush rating of CarMax (NYSE:KMX) on 12/20/2023
ASND Ascendis Pharma A/S	$125.95 -1.1%	12/20/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$200.00 -> $202.00	Low	View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 12/20/2023
AAPL Apple	$192.53 -0.5%	12/20/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/20/2023
GOSS Gossamer Bio	$0.91 +3.4%	12/19/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$6.00	Low	View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 12/19/2023
IMNM Immunome	$10.70 -0.3%	12/19/2023	Initiated by	Wedbush	Analyst D. Nierengarten	Outperform	$12.00	Low	View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 12/19/2023
DRI Darden Restaurants	$164.30 +0.0%	12/18/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$165.00 -> $177.00	Low	View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/18/2023
TPH Tri Pointe Homes	$35.40 -1.0%	12/18/2023	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$32.00	Low	View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 12/18/2023
TMHC Taylor Morrison Home	$53.35 -1.0%	12/18/2023	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$52.00	Low	View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 12/18/2023
SKY Skyline Champion	$74.26 -1.4%	12/18/2023	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$72.00	Low	View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 12/18/2023
MTH Meritage Homes	$174.20 -0.7%	12/18/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$170.00	Low	View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 12/18/2023
DOOR Masonite International	$84.66 -0.8%	12/18/2023	Downgraded by	Wedbush	-	Outperform -> Neutral	$92.00	Low	View details for Wedbush rating of Masonite International (NYSE:DOOR) on 12/18/2023
MHO M/I Homes	$137.74 -0.8%	12/18/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$116.00	Low	View details for Wedbush rating of M/I Homes (NYSE:MHO) on 12/18/2023
CCS Century Communities	$91.14 -0.5%	12/18/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$81.00	Low	View details for Wedbush rating of Century Communities (NYSE:CCS) on 12/18/2023
EXLS ExlService	$30.85 -0.3%	12/14/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$34.00	Low	View details for Wedbush rating of ExlService (NASDAQ:EXLS) on 12/14/2023
ACN Accenture	$350.91 -0.2%	12/14/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$330.00 -> $360.00	Low	View details for Wedbush rating of Accenture (NYSE:ACN) on 12/14/2023
PANW Palo Alto Networks	$294.88 -0.2%	12/14/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$290.00 -> $350.00	Low	View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 12/14/2023
ETSY Etsy	$81.05 -1.1%	12/14/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$60.00 -> $90.00	Low	View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 12/14/2023
VICI VICI Properties	$31.88 -0.9%	12/14/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$30.00	Low	View details for Wedbush rating of VICI Properties (NYSE:VICI) on 12/14/2023

TPX Tempur Sealy International	$50.97 -0.7%	12/13/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$50.00	Low	View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 12/13/2023
SLM SLM	$19.12 -0.8%	12/13/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$18.00 -> $21.00	Low	View details for Wedbush rating of SLM (NASDAQ:SLM) on 12/13/2023
COGT Cogent Biosciences	$5.88 -2.8%	12/11/2023	Downgraded by	Wedbush	Analyst D. Nierengarten	Outperform -> Neutral	$20.00 -> $5.00	Low	View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 12/11/2023
AAPL Apple	$192.53 -0.5%	12/11/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$240.00 -> $250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/11/2023
TXRH Texas Roadhouse	$122.23 -0.3%	12/11/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$120.00	Low	View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/11/2023
WD Walker & Dunlop	$111.01 -1.9%	12/11/2023	Target Raised by	Wedbush	-	Outperform	$90.00 -> $110.00	Low	View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 12/11/2023
LULU Lululemon Athletica	$511.29 +0.4%	12/8/2023	Target Raised by	Wedbush	-	Outperform	$420.00 -> $503.00	Low	View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 12/8/2023
SHOP Shopify	$77.90 -1.5%	12/6/2023	Reiterated by	Wedbush	Analyst S. Devitt	Outperform -> Neutral	$66.00 -> $68.00	Low	View details for Wedbush rating of Shopify (NYSE:SHOP) on 12/6/2023
VRDN Viridian Therapeutics	$21.78 -2.7%	12/4/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$37.00	Low	View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/4/2023
MLTX MoonLake Immunotherapeutics	$60.39 -1.8%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$92.00	Low	View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 12/1/2023
ARDX Ardelyx	$6.20 -3.4%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$9.00	Low	View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 12/1/2023
CROX Crocs	$93.41 -2.0%	12/1/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$96.00 -> $120.00	Low	View details for Wedbush rating of Crocs (NASDAQ:CROX) on 12/1/2023
DECK Deckers Outdoor	$668.43 -1.0%	12/1/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$650.00 -> $705.00	Low	View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 12/1/2023
CVNA Carvana	$52.94 -3.6%	12/1/2023	Reiterated by	Wedbush	Analyst S. Basham	Neutral -> Neutral	$40.00	Low	View details for Wedbush rating of Carvana (NYSE:CVNA) on 12/1/2023
ASO Academy Sports and Outdoors	$66.00 -0.2%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$60.00	Low	View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/1/2023
AMZN Amazon.com	$151.94 -0.9%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$180.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 12/1/2023
ESTC Elastic	$112.70 -1.1%	12/1/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$67.00	Low	View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/1/2023
TXRH Texas Roadhouse	$122.23 -0.3%	12/1/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$110.00 -> $120.00	Low	View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/1/2023
GME GameStop	$17.53 -3.0%	11/30/2023	Reiterated by	Wedbush	-	Underperform -> Underperform	$6.00	Low	View details for Wedbush rating of GameStop (NYSE:GME) on 11/30/2023
ABR Arbor Realty Trust	$15.18 -4.0%	11/30/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$17.00	Low	View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 11/30/2023
PVH PVH	$122.12 -0.9%	11/30/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$88.00	Low	View details for Wedbush rating of PVH (NYSE:PVH) on 11/30/2023
WOOF Petco Health and Wellness	$3.16 -3.4%	11/30/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$4.50 -> $3.50	Low	View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 11/30/2023
PSTG Pure Storage	$35.66 -1.1%	11/30/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$45.00 -> $40.00	Low	View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 11/30/2023
GM General Motors	$35.92 -0.8%	11/30/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$46.00 -> $40.00	Low	View details for Wedbush rating of General Motors (NYSE:GM) on 11/30/2023
CRM Salesforce	$263.14 -0.9%	11/30/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$255.00 -> $280.00	Low	View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/30/2023
OKTA Okta	$90.53 -0.9%	11/30/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of Okta (NASDAQ:OKTA) on 11/30/2023
ANAB AnaptysBio	$21.42 -1.1%	11/29/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$20.00	Low	View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/29/2023
TOL Toll Brothers	$102.79 -0.7%	11/29/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$82.00	Low	View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 11/29/2023
SHOO Steven Madden	$42.00 -1.8%	11/29/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$36.00	Low	View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 11/29/2023
BLDR Builders FirstSource	$166.94 -1.0%	11/29/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$175.00	Low	View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 11/29/2023
SKX Skechers U.S.A.	$62.34 -0.4%	11/29/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$59.00 -> $62.00	Low	View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 11/29/2023
AZO AutoZone	$2,585.61 +0.7%	11/29/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$2,750.00	Low	View details for Wedbush rating of AutoZone (NYSE:AZO) on 11/29/2023
NTAP NetApp	$88.16 -0.1%	11/29/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$75.00 -> $85.00	Low	View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/29/2023
CRNC Cerence	$19.66 -2.6%	11/28/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$31.00 -> $19.00	N/A	View details for Wedbush rating of Cerence (NASDAQ:CRNC) on 11/28/2023
TSLA Tesla	$248.48 -1.9%	11/28/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$310.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/28/2023
ZS Zscaler	$221.56 -1.3%	11/28/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$185.00 -> $210.00	Low	View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 11/28/2023
CRWD CrowdStrike	$255.32 -0.3%	11/28/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$200.00	Low	View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 11/28/2023
AAPL Apple	$192.53 -0.5%	11/24/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$240.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/24/2023
ASO Academy Sports and Outdoors	$66.00 -0.2%	11/22/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$60.00	Low	View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 11/22/2023
LOW Lowe's Companies	$222.55 -0.2%	11/22/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$230.00 -> $215.00	Low	View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 11/22/2023
DKS DICK'S Sporting Goods	$146.95 -0.3%	11/22/2023	Target Raised by	Wedbush	Analyst S. Basham	Neutral -> Neutral	$115.00 -> $130.00	Low	View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/22/2023
BBY Best Buy	$78.28 -0.2%	11/22/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$70.00	Low	View details for Wedbush rating of Best Buy (NYSE:BBY) on 11/22/2023
MSFT Microsoft	$376.04 +0.2%	11/22/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$425.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/22/2023
DNTH Dianthus Therapeutics	$10.40 +2.7%	11/22/2023	Initiated by	Wedbush	Analyst L. Chico	Outperform	$23.00	Low	View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 11/22/2023
SRPT Sarepta Therapeutics	$96.43 -1.4%	11/21/2023	Initiated by	Wedbush	-	Outperform	$224.00	Low	View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/21/2023
CAKE Cheesecake Factory	$35.01 -0.9%	11/20/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$32.00	Low	View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/20/2023
TSVT 2seventy bio	$4.27 -6.8%	11/20/2023	Downgraded by	Wedbush	Analyst D. Nierengarten	Outperform -> Neutral		Low	View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 11/20/2023
KBH KB Home	$62.46 -0.8%	11/20/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$55.00	Low	View details for Wedbush rating of KB Home (NYSE:KBH) on 11/20/2023
KRTX Karuna Therapeutics	$316.51 +0.1%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$253.00	Low	View details for Wedbush rating of Karuna Therapeutics (NASDAQ:KRTX) on 11/17/2023
OCS Oculis	$11.23 +1.2%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$29.00	Low	View details for Wedbush rating of Oculis (NASDAQ:OCS) on 11/17/2023

GLOB Globant	$237.98 -0.8%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Globant (NYSE:GLOB) on 11/17/2023
NVDA NVIDIA	$495.22	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$600.00	Low	View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/17/2023
RH RH	$291.48 -3.2%	11/17/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$335.00 -> $260.00	Low	View details for Wedbush rating of RH (NYSE:RH) on 11/17/2023
BZH Beazer Homes USA	$33.79 -1.0%	11/17/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$32.00	Low	View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 11/17/2023
WSM Williams-Sonoma	$201.78 -0.8%	11/17/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$150.00 -> $175.00	Low	View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 11/17/2023
NAPA Duckhorn Portfolio	$9.85 -1.6%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$15.00	Low	View details for Wedbush rating of Duckhorn Portfolio (NYSE:NAPA) on 11/17/2023
VIGL Vigil Neuroscience	$3.38 -8.4%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$23.00	Low	View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 11/17/2023
JACK Jack in the Box	$81.63 +0.2%	11/17/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$95.00 -> $72.00	Low	View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 11/17/2023
SWTX SpringWorks Therapeutics	$36.50 -2.0%	11/16/2023	Reiterated by	Wedbush	-	Outperform	$45.00	Low	View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/16/2023
EVH Evolent Health	$33.03 -1.5%	11/16/2023	Reiterated by	Wedbush	-	Outperform		Low	View details for Wedbush rating of Evolent Health (NYSE:EVH) on 11/16/2023
FI Fiserv	$132.84 -0.4%	11/16/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$150.00	Low	View details for Wedbush rating of Fiserv (NYSE:FI) on 11/16/2023
PANW Palo Alto Networks	$294.88 -0.2%	11/16/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$290.00	Low	View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 11/16/2023
MLTX MoonLake Immunotherapeutics	$60.39 -1.8%	11/16/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$86.00 -> $92.00	Low	View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/16/2023
MSFT Microsoft	$376.04 +0.2%	11/16/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$400.00 -> $425.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/16/2023
AAP Advance Auto Parts	$61.03 -0.7%	11/16/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$80.00 -> $60.00	Low	View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 11/16/2023
DKS DICK'S Sporting Goods	$146.95 -0.3%	11/16/2023	Reiterated by	Wedbush	Analyst S. Basham	Neutral -> Neutral	$115.00	Low	View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/16/2023
KMX CarMax	$76.74 -1.4%	11/16/2023	Target Lowered by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$90.00 -> $80.00	Low	View details for Wedbush rating of CarMax (NYSE:KMX) on 11/16/2023
UBX Unity Biotechnology	$1.93 +1.0%	11/16/2023	Upgraded by	Wedbush	Analyst A. Argyrides	Neutral -> Outperform	$4.00	Low	View details for Wedbush rating of Unity Biotechnology (NASDAQ:UBX) on 11/16/2023
BDSX Biodesix	$1.84 -3.2%	11/15/2023	Reiterated by	Wedbush	-	Outperform		Low	View details for Wedbush rating of Biodesix (NASDAQ:BDSX) on 11/15/2023
AFRM Affirm	$49.14 -4.4%	11/15/2023	Reiterated by	Wedbush	-	Underperform -> Underperform	$15.00	Low	View details for Wedbush rating of Affirm (NASDAQ:AFRM) on 11/15/2023
ALPN Alpine Immune Sciences	$19.06 -2.6%	11/15/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$26.00	Low	View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 11/15/2023
BJRI BJ's Restaurants	$36.01 -0.3%	11/15/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$33.00	Low	View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 11/15/2023
GETY Getty Images	$5.25 -3.0%	11/15/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$7.70	Low	View details for Wedbush rating of Getty Images (NYSE:GETY) on 11/15/2023
IMUX Immunic	$1.50 -3.2%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$7.00	Low	View details for Wedbush rating of Immunic (NASDAQ:IMUX) on 11/14/2023
TSVT 2seventy bio	$4.27 -6.8%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$7.00 -> $4.00	Low	View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 11/14/2023
YMAB Y-mAbs Therapeutics	$6.82 -7.7%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$12.00	Low	View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 11/14/2023
NUVL Nuvalent	$73.59 -2.0%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$74.00	Low	View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 11/14/2023
STRO Sutro Biopharma	$4.29 -1.6%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$12.00	Low	View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 11/14/2023
IGMS IGM Biosciences	$8.31 -5.5%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$19.00 -> $16.00	Low	View details for Wedbush rating of IGM Biosciences (NASDAQ:IGMS) on 11/14/2023
AVTE Aerovate Therapeutics	$22.63 -4.0%	11/14/2023	Reiterated by	Wedbush	-	Outperform	$48.00	Low	View details for Wedbush rating of Aerovate Therapeutics (NASDAQ:AVTE) on 11/14/2023
NYCB New York Community Bancorp	$10.23 -1.8%	11/14/2023	Downgraded by	Wedbush	Analyst D. Chiaverini	Neutral -> Underperform	$12.00 -> $8.00	Low	View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 11/14/2023
BEAM Beam Therapeutics	$27.22 -7.5%	11/13/2023	Reiterated by	Wedbush	-	Outperform	$48.00	Low	View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 11/13/2023
APGE Apogee Therapeutics	$27.94 -6.9%	11/13/2023	Reiterated by	Wedbush	Analyst D. Nierengarten	Outperform	$40.00	Low	View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 11/13/2023
ONON ON	$26.97 -3.5%	11/13/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$36.00	Low	View details for Wedbush rating of ON (NYSE:ONON) on 11/13/2023
SPRY ARS Pharmaceuticals	$5.48 -2.7%	11/13/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$5.00 -> $13.00	Low	View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 11/13/2023
KROS Keros Therapeutics	$39.76 -3.1%	11/13/2023	Reiterated by	Wedbush	Analyst A. Argyrides	Outperform -> Outperform	$86.00	Low	View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/13/2023
IBM International Business Machines	$163.55 -0.1%	11/13/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$140.00	Low	View details for Wedbush rating of International Business Machines (NYSE:IBM) on 11/13/2023
BPMC Blueprint Medicines	$92.24 +1.0%	11/10/2023	Reiterated by	Wedbush	-	Outperform	$80.00	Low	View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 11/10/2023
GOSS Gossamer Bio	$0.91 +3.4%	11/10/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$5.00 -> $6.00	Low	View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 11/10/2023
RLYB Rallybio	$2.39 -4.4%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$16.00 -> $14.00	Low	View details for Wedbush rating of Rallybio (NASDAQ:RLYB) on 11/10/2023
EWTX Edgewise Therapeutics	$10.94 -4.9%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$27.00 -> $23.00	Low	View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 11/10/2023
WD Walker & Dunlop	$111.01 -1.9%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$105.00 -> $90.00	Low	View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 11/10/2023
BBY Best Buy	$78.28 -0.2%	11/10/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$82.00 -> $70.00	Low	View details for Wedbush rating of Best Buy (NYSE:BBY) on 11/10/2023
PRPL Purple Innovation	$1.03 -4.6%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$3.00 -> $1.00	Low	View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 11/10/2023
GBIO Generation Bio	$1.65 -9.3%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$11.00 -> $9.00	Low	View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 11/10/2023
OMGA Omega Therapeutics	$3.01 -2.9%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$19.00 -> $12.00	Low	View details for Wedbush rating of Omega Therapeutics (NASDAQ:OMGA) on 11/10/2023
CCSI Consensus Cloud Solutions	$26.21 -2.3%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$42.00 -> $30.00	Low	View details for Wedbush rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/10/2023
U Unity Software	$40.89 -4.2%	11/10/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$55.00 -> $31.00	Low	View details for Wedbush rating of Unity Software (NYSE:U) on 11/10/2023
DBD Diebold Nixdorf	$28.95 +0.3%	11/10/2023	Target Raised by	Wedbush	Analyst M. Bryson	Neutral -> Neutral	$20.00 -> $25.00	Low	View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 11/10/2023
WSM Williams-Sonoma	$201.78 -0.8%	11/10/2023	Reiterated by	Wedbush	-	Neutral	$150.00	Low	View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 11/10/2023

STKS ONE Group Hospitality	$6.12 +0.5%	11/9/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$7.50 -> $5.25	Low	View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 11/9/2023
BIRD Allbirds	$1.23 -8.9%	11/9/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$1.50 -> $1.00	Low	View details for Wedbush rating of Allbirds (NASDAQ:BIRD) on 11/9/2023
CART Maplebear	$23.47 -1.6%	11/9/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$28.00 -> $30.00	Low	View details for Wedbush rating of Maplebear (NASDAQ:CART) on 11/9/2023
RBLX Roblox	$45.72 -1.5%	11/9/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$37.00 -> $49.00	Low	View details for Wedbush rating of Roblox (NYSE:RBLX) on 11/9/2023
LYFT Lyft	$14.99 -3.5%	11/9/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$11.00 -> $12.00	Low	View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 11/9/2023
APP AppLovin	$39.85 -2.2%	11/9/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$48.00 -> $58.50	Low	View details for Wedbush rating of AppLovin (NYSE:APP) on 11/9/2023
SKLZ Skillz	$6.24 -2.2%	11/9/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$20.00 -> $15.00	Low	View details for Wedbush rating of Skillz (NYSE:SKLZ) on 11/9/2023
FATE Fate Therapeutics	$3.74 -5.1%	11/9/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$6.00 -> $3.00	Low	View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 11/9/2023
TTWO Take-Two Interactive Software	$160.95 -0.3%	11/9/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$165.00	Low	View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 11/9/2023
SOFI SoFi Technologies	$9.95 -3.2%	11/9/2023	Reiterated by	Wedbush	Analyst D. Chiaverini	Underperform	$3.00	Low	View details for Wedbush rating of SoFi Technologies (NASDAQ:SOFI) on 11/9/2023
AFRM Affirm	$49.14 -4.4%	11/9/2023	Target Raised by	Wedbush	-	Underperform -> Underperform	$10.00 -> $15.00	Low	View details for Wedbush rating of Affirm (NASDAQ:AFRM) on 11/9/2023
BIIB Biogen	$258.77 -0.7%	11/9/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$266.00 -> $239.00	Low	View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 11/9/2023
ACET Adicet Bio	$1.89 +8.6%	11/9/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$17.00 -> $5.00	Low	View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 11/9/2023
XENE Xenon Pharmaceuticals	$46.06 -0.5%	11/9/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$47.00 -> $46.00	Low	View details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 11/9/2023
LQDA Liquidia	$12.03 -0.3%	11/9/2023	Reiterated by	Wedbush	-	Outperform	$3.00	Low	View details for Wedbush rating of Liquidia (NASDAQ:LQDA) on 11/9/2023
NCMI National CineMedia	$4.14 -4.2%	11/8/2023	Target Raised by	Wedbush	Analyst A. Reese	Neutral -> Neutral	$5.00	Low	View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 11/8/2023
CTMX CytomX Therapeutics	$1.55 +0.6%	11/8/2023	Upgraded by	Wedbush	-	Neutral -> Outperform	$2.00 -> $3.00	Low	View details for Wedbush rating of CytomX Therapeutics (NASDAQ:CTMX) on 11/8/2023
AQST Aquestive Therapeutics	$2.02 +1.0%	11/8/2023	Reiterated by	Wedbush	-	Outperform	$4.00	Low	View details for Wedbush rating of Aquestive Therapeutics (NASDAQ:AQST) on 11/8/2023
IDYA IDEAYA Biosciences	$35.58 -0.7%	11/8/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$43.00	Low	View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/8/2023
CAVA CAVA Group	$42.98 -3.7%	11/8/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$33.00 -> $35.00	Low	View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 11/8/2023
REPL Replimune Group	$8.43 -1.9%	11/8/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$52.00	Low	View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 11/8/2023
XNCR Xencor	$21.23 -0.9%	11/8/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$37.00 -> $36.00	Low	View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 11/8/2023
ASND Ascendis Pharma A/S	$125.95 -1.1%	11/8/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$192.00	Low	View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/8/2023
SNBR Sleep Number	$14.83 -2.6%	11/8/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$23.00 -> $12.00	Low	View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 11/8/2023
GPRO GoPro	$3.47 -1.1%	11/8/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$6.00 -> $5.00	Low	View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 11/8/2023
JANX Janux Therapeutics	$10.73 -8.3%	11/8/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$24.00	Low	View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 11/8/2023
SAGE Sage Therapeutics	$21.67 -1.8%	11/8/2023	Target Raised by	Wedbush	Analyst L. Chico	Neutral -> Neutral	$21.00 -> $22.00	Low	View details for Wedbush rating of Sage Therapeutics (NASDAQ:SAGE) on 11/8/2023
VIGL Vigil Neuroscience	$3.38 -8.4%	11/8/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$23.00	Low	View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 11/8/2023
UPST Upstart	$40.86 -7.5%	11/8/2023	Reiterated by	Wedbush	-	Underperform -> Underperform	$10.00	Low	View details for Wedbush rating of Upstart (NASDAQ:UPST) on 11/8/2023
GEO The GEO Group	$10.83 -3.7%	11/8/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$12.50 -> $14.00	Low	View details for Wedbush rating of The GEO Group (NYSE:GEO) on 11/8/2023
CXW CoreCivic	$14.53 -0.5%	11/8/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$14.00 -> $17.00	Low	View details for Wedbush rating of CoreCivic (NYSE:CXW) on 11/8/2023
DNLI Denali Therapeutics	$21.46 -2.2%	11/8/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$31.00	Low	View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 11/8/2023
ZNTL Zentalis Pharmaceuticals	$15.15 -2.8%	11/8/2023	Downgraded by	Wedbush	Analyst R. Driscoll	Outperform -> Neutral	$38.00 -> $12.00	Low	View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/8/2023
GFS GLOBALFOUNDRIES	$60.60 -1.5%	11/7/2023	Reiterated by	Wedbush	-	Outperform	$70.00	Low	View details for Wedbush rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 11/7/2023
UBER Uber Technologies	$61.57 -2.5%	11/7/2023	Reiterated by	Wedbush	-	Outperform	$55.00 -> $57.00	Low	View details for Wedbush rating of Uber Technologies (NYSE:UBER) on 11/7/2023
TRIP Tripadvisor	$21.53 +0.9%	11/7/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$17.00 -> $20.00	Low	View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2023
FUSN Fusion Pharmaceuticals	$9.61 -0.4%	11/7/2023	Reiterated by	Wedbush	-	Outperform	$13.00	Low	View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 11/7/2023
ITOS iTeos Therapeutics	$10.95 -0.8%	11/7/2023	Reiterated by	Wedbush	-	Outperform	$33.00	Low	View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 11/7/2023
INZY Inozyme Pharma	$4.26 -4.3%	11/7/2023	Reiterated by	Wedbush	-	Outperform	$15.00	Low	View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 11/7/2023
DHI D.R. Horton	$151.98	11/7/2023	Reiterated by	Wedbush	-	Neutral	$115.00	Low	View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 11/7/2023
BLUE bluebird bio	$1.38 -2.1%	11/7/2023	Reiterated by	Wedbush	-	Neutral	$7.00 -> $5.00	Low	View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 11/7/2023
CELH Celsius	$54.52 -1.7%	11/7/2023	Reiterated by	Wedbush	-	Outperform -> Outperform		Low	View details for Wedbush rating of Celsius (NASDAQ:CELH) on 11/7/2023
COIN Coinbase Global	$173.92 -6.7%	11/7/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$110.00	Low	View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 11/7/2023
DAWN Day One Biopharmaceuticals	$14.60 -2.6%	11/7/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$39.00 -> $35.00	Low	View details for Wedbush rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 11/7/2023
VTR Ventas	$49.84 -1.3%	11/7/2023	Upgraded by	Wedbush	Analyst R. Anderson	Neutral -> Outperform	$44.00 -> $51.00	Low	View details for Wedbush rating of Ventas (NYSE:VTR) on 11/7/2023
TAP Molson Coors Beverage	$61.21 -0.1%	11/6/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$70.00	Low	View details for Wedbush rating of Molson Coors Beverage (NYSE:TAP) on 11/6/2023
ELEV Elevation Oncology	$0.54 -1.8%	11/6/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$5.00	Low	View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 11/6/2023
MLTX MoonLake Immunotherapeutics	$60.39 -1.8%	11/6/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$86.00	Low	View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/6/2023
SBUX Starbucks	$96.01 +0.1%	11/6/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$100.00 -> $106.00	Low	View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 11/6/2023
HR Healthcare Realty Trust	$17.23 -1.2%	11/6/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$17.00	Low	View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 11/6/2023

SHOP Shopify	$77.90 -1.5%	11/3/2023	Target Raised by	Wedbush	-	Outperform	$62.00 -> $66.00	Low	View details for Wedbush rating of Shopify (NYSE:SHOP) on 11/3/2023
QLYS Qualys	$196.28 -1.0%	11/3/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$160.00 -> $170.00	Low	View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 11/3/2023
RDFN Redfin	$10.32 -1.7%	11/3/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$11.00 -> $8.00	Low	View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 11/3/2023
EXPE Expedia Group	$151.79 -1.0%	11/3/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$108.00 -> $115.00	Low	View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 11/3/2023
CYBR CyberArk Software	$219.05 -0.4%	11/3/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$185.00 -> $200.00	Low	View details for Wedbush rating of CyberArk Software (NASDAQ:CYBR) on 11/3/2023
CVCO Cavco Industries	$346.62 -1.7%	11/3/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$390.00	Low	View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 11/3/2023
PZZA Papa John's International	$76.23 -0.7%	11/3/2023	Target Lowered by	Wedbush	Analyst N. Setyan	Outperform -> Outperform	$95.00 -> $73.00	Low	View details for Wedbush rating of Papa John’s International (NASDAQ:PZZA) on 11/3/2023
CHUY Chuy's	$38.23 -1.1%	11/3/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$42.00 -> $41.00	Low	View details for Wedbush rating of Chuy’s (NASDAQ:CHUY) on 11/3/2023
BROS Dutch Bros	$31.67 -0.7%	11/3/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$37.00 -> $31.00	Low	View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 11/3/2023
DFH Dream Finders Homes	$35.53 -2.0%	11/3/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$16.00 -> $19.00	Low	View details for Wedbush rating of Dream Finders Homes (NASDAQ:DFH) on 11/3/2023
CVNA Carvana	$52.94 -3.6%	11/3/2023	Target Lowered by	Wedbush	Analyst S. Basham	Neutral -> Neutral	$48.00 -> $40.00	Low	View details for Wedbush rating of Carvana (NYSE:CVNA) on 11/3/2023
FND Floor & Decor	$111.56 -2.0%	11/3/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$90.00 -> $85.00	Low	View details for Wedbush rating of Floor & Decor (NYSE:FND) on 11/3/2023
BKNG Booking	$3,547.22 -0.1%	11/3/2023	Target Lowered by	Wedbush	Analyst S. Devitt	Outperform -> Outperform	$3,450.00 -> $3,300.00	Low	View details for Wedbush rating of Booking (NASDAQ:BKNG) on 11/3/2023
FCNCA First Citizens BancShares	$1,418.97 -1.3%	11/3/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$1,800.00	Low	View details for Wedbush rating of First Citizens BancShares (NASDAQ:FCNCA) on 11/3/2023
RKT Rocket Companies	$14.48 -3.5%	11/3/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$11.00 -> $8.00	Low	View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 11/3/2023
KRTX Karuna Therapeutics	$316.51 +0.1%	11/3/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$250.00 -> $253.00	Low	View details for Wedbush rating of Karuna Therapeutics (NASDAQ:KRTX) on 11/3/2023
ANAB AnaptysBio	$21.42 -1.1%	11/3/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$18.00 -> $20.00	Low	View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/3/2023
ALPN Alpine Immune Sciences	$19.06 -2.6%	11/3/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$19.00 -> $26.00	Low	View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 11/3/2023
TPX Tempur Sealy International	$50.97 -0.7%	11/3/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$55.00 -> $50.00	Low	View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 11/3/2023
KURA Kura Oncology	$14.38 +0.5%	11/3/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$40.00 -> $37.00	Low	View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 11/3/2023
EAT Brinker International	$43.18 -1.6%	11/2/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$33.00 -> $37.00	Low	View details for Wedbush rating of Brinker International (NYSE:EAT) on 11/2/2023
CAKE Cheesecake Factory	$35.01 -0.9%	11/2/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$32.00	Low	View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/2/2023
DIN Dine Brands Global	$49.65 -1.5%	11/2/2023	Target Lowered by	Wedbush	Analyst N. Setyan	Neutral -> Neutral	$54.00 -> $48.00	Low	View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/2/2023
RVLV Revolve Group	$16.58 -3.9%	11/2/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$19.00 -> $12.00	Low	View details for Wedbush rating of Revolve Group (NYSE:RVLV) on 11/2/2023
W Wayfair	$61.70 -3.8%	11/2/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$80.00 -> $65.00	Low	View details for Wedbush rating of Wayfair (NYSE:W) on 11/2/2023
ABNB Airbnb	$136.14 -0.6%	11/2/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$145.00 -> $135.00	Low	View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 11/2/2023
TENB Tenable	$46.06 -1.9%	11/2/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$55.00 -> $50.00	Low	View details for Wedbush rating of Tenable (NASDAQ:TENB) on 11/2/2023
DASH DoorDash	$98.89 -1.3%	11/2/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$85.00 -> $92.00	Low	View details for Wedbush rating of DoorDash (NYSE:DASH) on 11/2/2023
ALIT Alight	$8.53 -0.6%	11/2/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$13.00 -> $11.00	Low	View details for Wedbush rating of Alight (NYSE:ALIT) on 11/2/2023
ETSY Etsy	$81.05 -1.1%	11/2/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$70.00 -> $60.00	Low	View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 11/2/2023
NYCB New York Community Bancorp	$10.23 -1.8%	11/3/2023	Downgraded by	Wedbush	Analyst D. Chiaverini	Outperform -> Neutral	$12.00 -> $11.00	Low	View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 11/3/2023
FFWM First Foundation	$9.68 -2.1%	11/3/2023	Downgraded by	Wedbush	Analyst D. Chiaverini	Outperform -> Neutral	$7.00 -> $6.00	Low	View details for Wedbush rating of First Foundation (NASDAQ:FFWM) on 11/3/2023
CMA Comerica	$55.81 -1.3%	11/3/2023	Downgraded by	Wedbush	Analyst D. Chiaverini	Outperform -> Neutral	$47.00 -> $45.00	Low	View details for Wedbush rating of Comerica (NYSE:CMA) on 11/3/2023
FHN First Horizon	$14.16 -1.3%	11/3/2023	Upgraded by	Wedbush	Analyst D. Chiaverini	Neutral -> Outperform	$12.00 -> $14.00	Low	View details for Wedbush rating of First Horizon (NYSE:FHN) on 11/3/2023
EWBC East West Bancorp	$71.95 -1.2%	11/3/2023	Upgraded by	Wedbush	Analyst D. Chiaverini	Neutral -> Outperform	$57.00 -> $69.00	Low	View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 11/3/2023
VOR Vor Biopharma	$2.25 -13.5%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$11.00	Low	View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 11/2/2023
CMRX Chimerix	$0.96 +5.5%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$6.00	Low	View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/2/2023
SWTX SpringWorks Therapeutics	$36.50 -2.0%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$45.00	Low	View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/2/2023
IRON Disc Medicine	$57.76 +1.4%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$79.00	Low	View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/2/2023
NTLA Intellia Therapeutics	$30.49 -4.0%	11/2/2023	Reiterated by	Wedbush	-	Neutral	$45.00	Low	View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/2/2023
MELI MercadoLibre	$1,571.54 -0.6%	11/2/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$1,500.00	Low	View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 11/2/2023
VRNA Verona Pharma	$19.88 -1.4%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$33.00	Low	View details for Wedbush rating of Verona Pharma (NASDAQ:VRNA) on 11/2/2023
BMRN BioMarin Pharmaceutical	$96.42 -0.7%	11/2/2023	Reiterated by	Wedbush	-	Neutral	$78.00	Low	View details for Wedbush rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/2/2023
ROKU Roku	$91.66 -2.6%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$100.00	Low	View details for Wedbush rating of Roku (NASDAQ:ROKU) on 11/2/2023
HEAR Turtle Beach	$10.95	11/2/2023	Reiterated by	Wedbush	-	Outperform	$14.00	N/A	View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 11/2/2023
GPRO GoPro	$3.47 -1.1%	11/2/2023	Reiterated by	Wedbush	-	Outperform	$6.00	Low	View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 11/2/2023
UTHR United Therapeutics	$219.89 +0.3%	11/2/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$307.00 -> $308.00	Low	View details for Wedbush rating of United Therapeutics (NASDAQ:UTHR) on 11/2/2023
AMD Advanced Micro Devices	$147.41 -0.9%	11/1/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$155.00 -> $130.00	Low	View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 11/1/2023
AAPL Apple	$192.53 -0.5%	11/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$240.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/1/2023
CELH Celsius	$54.52 -1.7%	11/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$75.00	Low	View details for Wedbush rating of Celsius (NASDAQ:CELH) on 11/1/2023
SRRK Scholar Rock	$18.80 -7.5%	10/31/2023	Reiterated by	Wedbush	-	Outperform	$23.00	Low	View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 10/31/2023
UFPI UFP Industries	$125.55 -1.3%	10/31/2023	Reiterated by	Wedbush	-	Neutral	$102.00	Low	View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 10/31/2023
ASND Ascendis Pharma A/S	$125.95 -1.1%	10/31/2023	Reiterated by	Wedbush	-	Outperform	$192.00	Low	View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 10/31/2023
MRSN Mersana Therapeutics	$2.32 -0.9%	10/31/2023	Reiterated by	Wedbush	Analyst D. Nierengarten	Neutral	$2.00	Low	View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 10/31/2023
KNSA Kiniksa Pharmaceuticals	$17.54 -1.7%	10/31/2023	Reiterated by	Wedbush	-	Outperform	$23.00	Low	View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 10/31/2023
BEAM Beam Therapeutics	$27.22 -7.5%	10/31/2023	Reiterated by	Wedbush	-	Outperform	$48.00	Low	View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 10/31/2023
HMST HomeStreet	$10.30 -4.5%	10/31/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$8.00 -> $6.00	Low	View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 10/31/2023
PEAK Healthpeak Properties	$19.80 -1.9%	10/31/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$19.00	Low	View details for Wedbush rating of Healthpeak Properties (NYSE:PEAK) on 10/31/2023
VRDN Viridian Therapeutics	$21.78 -2.7%	10/31/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$46.00 -> $37.00	Low	View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 10/31/2023
VFC V.F.	$18.80 -1.4%	10/31/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$20.00 -> $15.00	Low	View details for Wedbush rating of V.F. (NYSE:VFC) on 10/31/2023

MarketBeat Community Rating for Wedbush

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		22,630 (Vote Outperform)
Underperform Votes:		19,318 (Vote Underperform)
Total Votes:		41,948

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms. Vote "Outperform" if you believe Wedbush's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Wedbush Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Wedbush

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info